Impact of dupilumab on medical readiness in a military population.

Gregory S HillMichael W NollerCristianah O OlubajoAnthony M TolisanoCharles A Riley Jakob L Fischer

Published in: International forum of allergy & rhinology (2023)

Military servicemembers reported high satisfaction rates of dupilumab treatment for CRSwNP. Some service members fear that dupilumab treatment may limit their career progression. Updated guidelines are needed for servicemembers to make decisions regarding dupilumab.

Keyphrases

atopic dermatitis
healthcare
mental health
posttraumatic stress disorder
medical students